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Vascular Department, University of Poitiers, Medical School, Hospital Jean Bernard, 86021 Poitiers, FranceThe beneﬁts of standard endovascular grafts (EVAR) for
abdominal aortic aneurysm (AAA) have been well docu-
mented in terms of 30 day mortality, length of stay, and
early cost-effectiveness compared with open surgical repair
(OSR). However, these standard stent grafts are not well
adapted to complex aortic aneurysms with a short neck or
involving the visceral arteries. In this issue of the European
Journal of Vascular and Endovascular Surgery, Michel et al.1
present an interesting study comparing outcomes and costs
of f/b EVAR and OSR for complex AAA.
The study design is that of the WINDOW registry, which
has previously been published.2 In this registry the control
group of patients (OSR) was extracted from the French
National Hospital Discharge Database (PMSI). Therefore, the
study compares a group of patients at high risk for OSR
receiving f/b EVAR in selected centres (the cases, n ¼ 268)
with a large group of patients at acceptable risk for OSR
(controls, n ¼ 1,678). Although risk adjustments using the
Charlson index improved the comparison between these
two groups, most of the comorbidities could not be
adjusted, resulting in an analysis comparing two different
techniques in two different populations.
Furthermore, clinical outcomes and costs were not
evaluated in the same way in the two groups. The data for
f/b EVAR cases were extracted from a complete case report
ﬁle (CRF), compared with the cases where data were issued
from the coding of the national discharge administrative
database. As an example, matches corresponding to thor-
acoabdominal aneurysms versus juxtarenal aortic aneu-
rysms in the infra-diaphragmatic area were identiﬁed in
“cases” by reviewing pre-operative CT scans, whereas for
“controls,” the matches relied on the coding system alone
with no access to the patients’ charts. As suggested by the
authors, the data available from the control group are
subject to coding incentives and more likely to contain
comorbidities that impact the level of reimbursement.DOI of original article: http://dx.doi.org/10.1016/j.ejvs.2015.04.012
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http://dx.doi.org/10.1016/j.ejvs.2015.07.004The authors correctly point out that a randomised study
would have been difﬁcult to organise, because of the
relatively low number of patients with complex aortic
aneurysms and the discrepancy between the large number
of centres currently performing OSR for complex aortic
aneurysms and the small number of those trained for f/b
EVAR. Interestingly, a comparison limited to the f/b centres
appeared impossible because these centres had switched to
endovascular repair and could not provide a sufﬁciently
large OSR group for “controls.”
Even without randomisation, an independent review of
the patients’ charts and CT scans in the control group would
have added to the value of the study.
Concerning economic evaluation, only acute hospital re-
sources <30 days were considered for the two groups with
a micro-costing approach for all f/b EVAR patients including
graft components and other supplies recorded in the CRF or
retrieved from the surgical ward database. On the contrary,
costs for controls were not evaluated using a micro-costing
approach as the authors had no access to individual patient
ﬁles; data were taken from the national hospital cost sta-
tistics and adjusted according to length of stay and other
variables.
At 30 days, a multivariate Cox regression analysis where
age, sex, group, and Charlson index were taken into account
found no signiﬁcant impact of treatment (f/b EVAR vs. OSR)
on mortality (HR 0.97, 95% CI 0.57-1.66) but a signiﬁcant
association with age and type of aneurysm. Finally, f/b EVAR
was predictably more costly than OSR, particularly for para/
juxtarenal AAA (33,919 V vs. 14,661 V) and for infra-
diaphragmatic TAAA (37,517 V vs. 17,239 V).
The authors conclude that f/b EVAR appeared unjustiﬁed
for ﬁt patients with para/juxtarenal and infradiaphragmatic
aortic aneurysm but that this might be attractive for pa-
tients unﬁt for surgery and for any patient with supra-
diaphragmatic TAAA.
This study highlights the complexity of the evaluation of
f/b EVAR. Given the limitations of their study, the authors
were probably right to say that f/b EVAR does not appear
to be justiﬁed in ﬁt patients with para/juxtarenal aortic
aneurysm. In these cases a retroperitoneal approach with
an eventual bypass to the renal arteries is a straightforward
procedure with low mortality and morbidity. On the other
198 J.-B. Ricco and F. Schneiderhand, when the AAA extends above the superior mesenteric
artery, the morbidity of OSR is signiﬁcantly higher, even in
ﬁt patients, and evaluation of f/b EVAR as an alternative is
needed.
This study, which is the ﬁrst to analyse the cost-
effectiveness of f/b EVAR, adds important data to the cur-
rent debate. It also raises several important questions
regarding the management of complex abdominal aortic
aneurysms. Analysing the pros and cons of this study, it
appears that f/b EVAR should be assessed in two separate
populations: (1) f/b EVAR vs. OSR in patients ﬁt for open
repair, and (2) f/b EVAR vs. no surgery, i.e. best medical
therapy, in patients unﬁt for open repair.
The effectiveness of the treatment should ideally be
focused on RCT data or, if this is not realistic,3 on
comparative prospective studies with a similar protocol in
both arms including careful economic evaluation with
micro-costing. Fitness of patients for OSR can be deter-
mined on the basis of the criteria used for the EVAR trials.4
In addition to aneurysm size, number of target vessels and
type of OSR leading to variation of the operative risk should
also be included in the randomisation or, at least, in the
evaluation process. As shown by the authors and by others
as well,5 such a trial may be difﬁcult to carry out because of
the limited number of centres with a large f/b EVAR and
OSR experience for complex AAA.Finally, these studies should not be limited to the 30 day
outcome, but rather extended to include long-term follow
up involving survival analysis, results of target vessel
revascularisation, assessment of renal function, and rein-
tervention rates.REFERENCES
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